Plaque composition in plexogenic and thromboembolic pulmonary hypertension:: the critical role of thrombotic material in pultaceous core formation

被引:110
作者
Arbustini, E
Morbini, P
D'Armini, AM
Repetto, A
Minzioni, G
Piovella, F
Viganò, M
Tavazzi, L
机构
[1] IRCCS, Policlin San Matteo, Mol Diagnost Cardiovasc & Transplant Pathol Lab, Tranaplant Res Area, Pavia, Italy
[2] IRCCS, Policlin San Matteo, Dept Pathol, Pavia, Italy
[3] IRCCS, Policlin San Matteo, Dept Cardiac Surg, Pavia, Italy
[4] IRCCS, Policlin San Matteo, Thromboembolism Unit, Pavia, Italy
[5] IRCCS, Policlin San Matteo, Dept Cardiol, Pavia, Italy
[6] Spedali Civil Brescia, Cardiac Surg Unit, I-25125 Brescia, Italy
关键词
D O I
10.1136/heart.88.2.177
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with pulmonary hypertension develop intimal plaques in large pulmonary arteries. Objective: To test the hypothesis that the composition of such plaques differs depending on whether the aetiology of the disease is thromboembolic or hypertensive. Design: Chronic thromboembolic and plexogenic pulmonary hypertension (primary and secondary (Eisenmenger syndrome)) were investigated. These are spontaneous human models and were used to examine the independent role of thrombus and hypertension in plaque composition. Setting: A national tertiary referral centre for lung transplantation and pulmonary thromboendoarterectomy. Patients: Thirty nine patients with chronic thromboembolic pulmonary hypertension who had undergone thromboendoarterectomy (n = 32) or lung transplantation (n = 7), 28 with plexogenic diseases (nine primary and 19 Eisenmenger), and three with Eisenmenger syndrome complicated by thromboembolic events. Interventions: The lung and thromboendoarterectomy samples were sectioned, stained with Movat pentachrome, and immunostained with antibodies for fibrin, platelets, inflammatory cells, smooth muscle cells, and erythrocyte membrane glycophorin A. Main outcome measure: Composition of the plaques affecting large pulmonary arteries. Results: Two types of intimal lesion were distinguished in chronic thromboembolic pulmonary hypertension: fibrous plaques with angioneogenesis; and core-rich atherosclerotic plaques with pultaceous cores largely consisting of glycophorin immunoreactive material, with cholesterol clefts (61.5%), CD68 positive macrophages (84.6%), T lymphocytes (87%), and calcification (46.1%). The samples from the patients with Eisenmenger syndrome and thromboembolic complications had similar characteristics, whereas those from patients with uncomplicated primary pulmonary hypertension had core-free fibrous plaques, spotted with macrophages and T lymphocytes. Conclusions: Chronic thromboembolic pulmonary hypertension is associated with atherosclerotic plaques with glycophorin-rich pultaceous cores, and plexogenic pulmonary hypertension with fibrous plaques. Thromboembolic material thus plays a critical role in the formation of pultaceous cores, of which erythrocyte membrane derived glycophorin is a major component.
引用
收藏
页码:177 / 182
页数:6
相关论文
共 17 条
[1]   COMPARISON OF CORONARY LESIONS OBTAINED BY DIRECTIONAL CORONARY ATHERECTOMY IN UNSTABLE ANGINA, STABLE ANGINA, AND RESTENOSIS AFTER EITHER ATHERECTOMY OR ANGIOPLASTY [J].
ARBUSTINI, E ;
DESERVI, S ;
BRAMUCCI, E ;
PORCU, E ;
COSTANTE, AM ;
GROSSO, M ;
DIEGOLI, M ;
FASANI, R ;
MORBINI, P ;
ANGOLI, I ;
BOSCARINI, M ;
REPETTO, S ;
DANZI, G ;
NICCOLI, L ;
CAMPOLO, L ;
LUCREZIOTTI, S ;
SPECCHIA, G .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (10) :675-682
[2]   Immunohistochemical characterization of coronary thrombi in allograft vascular disease [J].
Arbustini, E ;
Dal Bello, B ;
Morbini, P ;
Gavazzi, A ;
Specchia, G ;
Viganò, M .
TRANSPLANTATION, 2000, 69 (06) :1095-1101
[3]   PRIMARY PULMONARY-HYPERTENSION - A HISTOPATHOLOGIC STUDY OF 80 CASES [J].
BJORNSSON, J ;
EDWARDS, WD .
MAYO CLINIC PROCEEDINGS, 1985, 60 (01) :16-25
[4]  
Boesze-Battaglia K, 1997, J EXP BIOL, V200, P2927
[5]  
Cattaneo M, 1999, THROMB HAEMOSTASIS, V81, P165
[6]   Functional aspects of red cell antigens [J].
Daniels, G .
BLOOD REVIEWS, 1999, 13 (01) :14-35
[7]   EXPERIENCE AND RESULTS WITH 150 PULMONARY THROMBOENDARTERECTOMY OPERATIONS OVER A 29-MONTH PERIOD [J].
JAMIESON, SW ;
AUGER, WR ;
FEDULLO, PF ;
CHANNICK, RN ;
KRIETT, JM ;
TARAZI, RY ;
MOSER, KM .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1993, 106 (01) :116-127
[8]   Haemostatic parameters and vascular risk [J].
JuhanVague, I .
ATHEROSCLEROSIS, 1996, 124 :S49-S55
[9]  
LITHELL H, 1994, AM J HYPERTENS, V7, pS15
[10]  
MOORE GW, 1982, ARCH PATHOL LAB MED, V106, P378